SIFIC2011 Speakers
讲者－Lindsay Grayson，ICAAC主席
Professor M. Lindsay Grayson, MBBS, MD, MSc, FRACP, FAFPHM
Prof. M. Lindsay Grayson graduated from Monash University Medical School in 1979 and completed Infectious Diseases training at New England Deaconess Hospital, Harvard Medical School, Boston in 1991; he completed his MD research thesis in 1994 and Master of Science (MSc) in Clinical Epidemiology & Clinical Effectiveness, Harvard School of Public Health, Boston in 1997. From 1991-2000, he was Deputy Director, then Director, of the Infectious Diseases and Clinical Epidemiology, Monash Medical Centre, Melbourne. Since 2000, Prof. Grayson has been Director of Infectious Diseases and Microbiology, Austin Health and Professor of Infectious Diseases, Department of Medicine, University of Melbourne. Prof. Grayson is immediate Past-President of the Australasian Society for Infectious Diseases and is currently Chair of the Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC) Program Committee for the American Society for Microbiology. He has had a longstanding interest in antimicrobial resistance, particularly related to staphylococci and enterococci and infection control. He is Editor-in-Chief of the recently released ASM text, Kucers' "Use of Antibiotics", 6th edition (2010) and co-editor of .”Emerging Infections” (ASM, 2010).
Recent Publications
1. Young HL, Ballard SA, Roffey P, Grayson ML. Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage - sensitive but not specific. J Antimicrob Chemother 2007; 59:809-10.
2. Brown TL, Gamon S, Tester P, Martin R, Hosking K, Bowkett GC, Gerostamoulos D, Grayson ML. Can Alcohol-based Hand-rub Solutions cause you to lose your driver's licence? Comparative cutaneous absorption of various alcohols. Antimicrob Agents Chemother 2007; 51:1107-8.
3. Dendle C, Mulvy S, Pyrlis F, Grayson ML, Johnson PDR. Severe complications of a "Brazilian" bikini wax. Clin Infect Dis 2007; 45:e29-31.
4. Charles PGP, Grayson ML. Point of care tests for lower respiratory tract infections. Med J Aust 2007; 187:36-39.
5. Walton AL, Howden BP, Grayson ML, Korman TM. Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens. Intern J of Antimicrob Chemother 2007; 29: 544-548.
6. Ananda-Rajah MR, Charles PGP, Melvani S, Burrell LL, Johnson PDR, Grayson ML. Comparing the pneumonia severity index with CURB-65 in patients with community-acquired pneumonia. Scand J Infect Dis. 2007:1-8.
7. Swaminathan A, Martin R, Gamon S, Aboltins C, Athan E, Braitberg G, Catton M, Cooley L, Dwyer D, Edmonds D, Eisen D, Hosking K, Hughes A, Johnson PDR, McLeod A, O'Reilly M, Peters E, Stuart RL, Moran R, Grayson ML. Quantifying personal protective equipment (PPE) and antiviral use during the initial acute management of suspected human cases of pandemic influenza. Emerg Infect Dis 2007; 13:1541-7.
8. McMahon JH, O'Keeffe JM, The Victorian HITH Outcomes Study Group, Grayson ML. Is Hospital-in-the-Home treatment of bacterial endocarditis safe and effective?Scand J Infect Dis. 2008;40:40-3.
9. Collignon PJ, Grayson ML, Johnson PDR.Methicillin-resistant Staphylococcus aureus in hospitals: time for a culture change. Med J Aust 2007; 187:4-5.
10. McMahon JH, Grayson ML. Torsade de pointes in a patient receiving fluconazole for cerebral cryptococcosis. Am J Health Sys Pharm. 2008; 65(7):619-23.
11. Chua K, Gürtler V, Montgomery J, Mayall BC, Grayson ML. Campylobacter insulaenigrae causing septicemia and enteritis. J Med Microbiol. 2007; 56:1565-1567.
12. Waterer GW, Grayson ML. The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia. Intern Med J 2007; 37:789-91.
13. Graham M, Ballard SA, Grabsch EA, Johnson PDR, Grayson ML. High rates of fecal carriage with non-enterococcal vanB - evidence for an age-related increase between children and adults. Antimicrob Agents Chemother 2008; 52:1195-1197.
14. Charles PGP, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJP, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, the ACAPS Collaboration, Grayson ML. The eitiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008; 46:1513-21.
15. Charles PGP, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJP, Mayall BC, Armstrong JG, Korman TM, Holmes PW, Obrosky DS, Peyrani P, Johnson B, Hooy M, the ACAPS Collaboration, Grayson ML. SMART-COP: a tool for predicting intensive respiratory or inotropic support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375-84.
16. Charles PG, Wolfe R, Grayson ML. Reply to Chalmers and Hill. Clin Infect Dis 2008; 47:1364.
17. Grayson ML, Jarvie LJ, Martin R, Johnson PD, Jodoin ME, McMullan C, Gregory RH, Bellis K, Cunnington K, Wilson FL, Quin D, Kelly AM; Hand Hygiene Study Group and Hand Hygiene Statewide Roll-out Group, Victorian Quality Council. Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent successful statewide roll-out. Med J Aust. 2008;188:633-40.
18. Grabsch EA, Chua K, Xie S, Byrne J, Ballard SA, Ward PB, Grayson ML. Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by E-test using oxgall supplementation. J Clin Microbiol 2008; 46:1961-4.
19. Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PDR, Birch C. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza on the hands of human volunteers. Clin Infect Dis 2009; 2009; 48:285-91.
20. Dendle C, Ballard SA, Grabsch EA, Gao W, Grayson ML. Outbreak of vancomycin resistant Enterococcus faecium containing both vanA and vanB gene clusters. J Hosp Infect. 2009; 71 (4):379-381.
21. Domingo MC, Huletsky A, Boissinot M, Hélie MC, Bernal A, Bernard KA, Grayson ML, Picard FJ, Bergeron MG. Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol. 2009; 59(Pt 3):498-503.
22. Charles PG, Davis JS, Grayson ML. Rocket science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines for severe community-acquired pneumonia. Clin Infect Dis. 2009 48:1796.
23. Johnson D.F, Druce J.D, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009; 49(2):275-7.
24. Horne KC, Howden BP, Graham M, Ward PB, Grabsch EA, Xie S, Mayall BC, Johnson PDR, Grayson ML. Prospective comparison of the clinical pathogenicity of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (hVISA/VISA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother. 2009; 53:3447-52.
25. Grayson ML, Johnson PD. Australia's influenza containment plan and the swine flu epidemic in Victoria. Med J Aust. 2009; 191:150.
26. Kelley PG, Grabsch EA, Howden BP, Gao W, Grayson ML. Comparison of the XpertÔ MRSA Assay, BD GeneOhmÔ MRSA Assay and Culture for the Detection of Nasal and Cutaneous Groin Colonization by Methicillin-Resistant Staphylococcus aureus (MRSA). J Clin Microbiol. 2009:
27. Dendle C, Martin RD, Cameron DR, Grabsch EA, Mayall BC, Grayson ML, Johnson PDR. Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control. Med J Aust 2009; 191: 389-392.
28. Grayson ML, Russo P. The Australian hand hygiene initiative. Med J Aust 2009; 191: 420-1.
29. Stewardson A, Grayson ML. Psittacosis. Infect Dis Clinics Nth America. 2010; 24(1):7-25.
30. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML.Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.Clin Microbiol Rev. 2010; 23: 99-139.
31. Gordon CL, Johnson PDR, Permezel M, Holmes NE, Gutteridge G, McDonald CF, Eisen DP, Stewardson AJ, Edington J, Charles PGP, Crinis N, Black MJ, Grayson ML. Association between severe swine-origin influenza A (H1N1) virus (S-OIV) infection and immunoglobulin G2 subclass deficiency. Clin Infect Dis 2010; 50:672-8.
32. Johnson PD, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Grayson ML, Howden BP. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. J Infect Dis. 2010; 202:1278-86.
33. Gordon CL, Langan K, Charles PGP, Bellomo R, Hart GK, Torresi J, Johnson PDR, Grayson ML. Pooled Human Immunoglobulin therapy in Critically ill patients with Pandemic 2009 Influenza A (H1N1) Pneumonitis and Immunoglobulin G2 subclass (IgG2) Deficiency. Clin Infect Dis 2011; 52:422-6.
34. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis. 2011; 52: 99-114.
|
#AI工具#
上传视频拿金币，快来上传你最喜爱的感控相关视频吧！#👈点我了解详情#
发表于 2012-2-14 16:00
发表于 2012-2-14 16:41
发表于 2012-2-14 20:43
